[Electrocardiographic changes with the use of aminophylline and salbutamol in adult patients with chronic bronchial asthma]
- PMID: 1792478
[Electrocardiographic changes with the use of aminophylline and salbutamol in adult patients with chronic bronchial asthma]
Abstract
Fifteen patients diagnosed with bronchial asthma were examined to evaluate the cardiotoxicity caused by the combined intravenous treatment using methylxanthine-aminophylline 250 mg and a beta agonist: salbutamol 0.5 mg. The following observations were made: four patients had sinus tachycardia and another suffered from ventricular extrasystoles as seen in the electrocardiographic register; another two patients had sinus tachycardia when the bronchial dilator dosage was doubled. From a clinical and electrocardiographic standpoint, arrhythmias do not seem to be a grave problem among the population studied.
Similar articles
-
Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.N Z Med J. 1987 May 27;100(824):309-11. N Z Med J. 1987. PMID: 3330186 Clinical Trial.
-
Comparison of intravenous salbutamol (albuterol) and aminophylline in the treatment of acute asthmatic attacks.Ann Allergy. 1985 Sep;55(3):504-6. Ann Allergy. 1985. PMID: 3898925 Clinical Trial.
-
Plasma potassium in acute severe asthma before and after treatment.Br J Clin Pract. 1989 Oct;43(10):363-5. Br J Clin Pract. 1989. PMID: 2629946
-
Best evidence topic reports. Is intravenous aminophylline better than intravenous salbutamol in the treatment of moderate to severe asthma?Emerg Med J. 2004 Jan;21(1):78-80. Emerg Med J. 2004. PMID: 14734389 Free PMC article. Review.
-
Aminophylline treatment in severe, acute asthma. A meta-analysis.JAMA. 1988 Mar 18;259(11):1678-84. JAMA. 1988. PMID: 3278146 Review.